A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis (SYCAMORE)

Funder: HTA


Project Summary: Randomised, double-blind, placebo-controlled, multicentre, trial of adalimumab in combination with methotrexate (MTX) in patients with active uveitis in association with JIA refractory to s/c MTX monotherapy. Participants (154) will be randomised applying a ratio of 2:1 (in favour of adalimumab).


Links: http://www.sycamoretrial.org.uk/